<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00884351</url>
  </required_header>
  <id_info>
    <org_study_id>090125</org_study_id>
    <secondary_id>09-N-0125</secondary_id>
    <nct_id>NCT00884351</nct_id>
  </id_info>
  <brief_title>Magnetoencephalography in Absence Seizures</brief_title>
  <official_title>Magnetoencephalography in Absence Seizures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
        -  An absence seizure is a type of seizure that usually begins in childhood and goes away&#xD;
           by early adulthood. Scientists do not yet know where absence seizures begin in the&#xD;
           brain. Some evidence suggests that these seizures begin in the thalamus, a structure&#xD;
           deep in the brain, but other studies suggest that they begin in the frontal cortex, at&#xD;
           the front part of the brain.&#xD;
&#xD;
        -  Magnetoencephalography is a type of brain scanning procedure that is useful in&#xD;
           determining information about what happens to the brain during epileptic seizures.&#xD;
           Understanding where absence seizures come from may help doctors find new treatments for&#xD;
           them.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
        -  To gain a better understanding of which parts of the brain are affected in absence&#xD;
           seizures.&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
        -  Patients 7 to 35 years of age who have been diagnosed with absence seizures.&#xD;
&#xD;
      Design:&#xD;
&#xD;
        -  Procedures are for research purposes only, not to diagnose or treat a particular medical&#xD;
           condition.&#xD;
&#xD;
        -  Two outpatient visits to the National Institutes of Health Clinical Center: evaluation&#xD;
           and scanning.&#xD;
&#xD;
        -  Researchers will evaluate potential participants with a medical history, physical&#xD;
           examination, and electroencephalography (EEG). These tests will be performed under&#xD;
           another protocol, 01-N-0139.&#xD;
&#xD;
        -  Patients will undergo magnetoencephalography (MEG) and magnetic resonance imaging (MRI)&#xD;
           of the brain. The study procedures will be performed one time; however, an MEG or MRI&#xD;
           scan may need to be repeated for technical reasons. Researchers will not do more than&#xD;
           two MEG or MRI scans.&#xD;
&#xD;
        -  The MEG will record very small magnetic field changes produced by the activity of the&#xD;
           brain. An EEG will be recorded at the same time as the MEG.&#xD;
&#xD;
        -  The MRI will use a magnetic field to take pictures of the inside of the brain.&#xD;
&#xD;
        -  The MEG will take 3 hours to complete (2 hours for preparation, 1 hour in the scanner).&#xD;
           The MRI will take approximately 1 hour.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective:&#xD;
&#xD;
      This protocol will test the hypothesis that the 3-Hz spike-wave discharges seen in absence&#xD;
      epilepsy originate in the thalamus. We will use an emerging modality, magnetoencephalograpy&#xD;
      (MEG), to test this hypothesis.&#xD;
&#xD;
      Study Population:&#xD;
&#xD;
      33 patients with absence seizures.&#xD;
&#xD;
      Design:&#xD;
&#xD;
      This is a non-invasive imaging study that involves a 275-channel whole head MEG recording and&#xD;
      a structural MRI for co-registration of MEG data.&#xD;
&#xD;
      Outcome Measure:&#xD;
&#xD;
      The primary outcome measure is the source localization of spike-wave discharges on&#xD;
      magnetoencephalography.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 15, 2009</start_date>
  <completion_date>June 15, 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">5</enrollment>
  <condition>Seizures</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
               1. Age 7-35&#xD;
&#xD;
               2. Absence of seizures based on clinical and electroenecephalography data. Patients&#xD;
                  who have other seizure types (myoclonic, generalized tonic-clonic) in addition to&#xD;
                  absence seizures may be included.&#xD;
&#xD;
               3. Patients who have other neurologic disorders may be included, as long as they are&#xD;
                  able to consent/assent.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          1. Contraindications to MEG studies (Dental braces, permanent retainers, metal dental&#xD;
             caps/crowns/fillings)&#xD;
&#xD;
          2. Contraindications to MRI studies (such as pacemakers, cochlear devices, surgical&#xD;
             clips, metallic implants, orthopedic pins, shrapnel, permanent eyeliner, vagus nerve&#xD;
             stimulator)&#xD;
&#xD;
          3. Claustrophobia or anxiety disorders exacerbated by MRI&#xD;
&#xD;
          4. Pregnancy&#xD;
&#xD;
          5. Inability to provide consent/assent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Avoli M, Gloor P. Role of the thalamus in generalized penicillin epilepsy: observations on decorticated cats. Exp Neurol. 1982 Aug;77(2):386-402.</citation>
    <PMID>7095066</PMID>
  </reference>
  <reference>
    <citation>Bernasconi A, Bernasconi N, Natsume J, Antel SB, Andermann F, Arnold DL. Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy. Brain. 2003 Nov;126(Pt 11):2447-54. Epub 2003 Aug 5.</citation>
    <PMID>12902313</PMID>
  </reference>
  <reference>
    <citation>Castro-Alamancos MA. Neocortical synchronized oscillations induced by thalamic disinhibition in vivo. J Neurosci. 1999 Sep 15;19(18):RC27.</citation>
    <PMID>10479720</PMID>
  </reference>
  <verification_date>June 15, 2011</verification_date>
  <study_first_submitted>April 17, 2009</study_first_submitted>
  <study_first_submitted_qc>April 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2009</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <keyword>Epilepsy</keyword>
  <keyword>MEG</keyword>
  <keyword>Seizures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Epilepsy, Absence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

